Rong Tang

Rong Tang

Auto-generated profile, based on publicly available information

Rong Tang

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ZRZeyin Rong
Zeyin Rong
JXJin Xu
Jin Xu
JYJianhui Yang
Jianhui Yang
WWWei Wang
Wei Wang
RTRong Tang
Rong Tang
SSSi Shi
Si Shi
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal tumor with limited treatment options and poor patient survival. Circular RNAs (circRNA) play crucial regulatory roles in the occurrence and development of various cancers, including PDAC. In this study, using circRNA sequencing of diverse PDAC samples, we identified circRREB1 as an oncogenic circRNA that is significantly upregulated in PDAC and is correlated with an unfavorable patient prognosis. Functionally, loss of circRREB1 markedly inhibited glycolysis and stemness, whereas elevated circRREB1 elicited the opposite effects. Mechanistically, circRREB1 interacted with PGK1, disrupting the association between PTEN and PGK1 and increasing PGK1 phosphorylation to activate glycolytic flux. Moreover, circRREB1 promoted WNT7B transcription by directly interacting with YBX1 and facilitating its nuclear translocation, consequently activating the Wnt/β-catenin signaling pathway to maintain PDAC stemness. Overall, these results highlight circRREB1 as a key regulator of metabolic and stemness properties of PDAC. Significance: CircRREB1 stimulates PGK1 to induce glycolysis and activates the Wnt/β-catenin signaling pathway to maintain stemness in pancreatic cancer, indicating the potential of circRREB1 as a biomarker and therapeutic target.

26 March 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
ZWZijian Wu
Zijian Wu
JXJin Xu
Jin Xu
RTRong Tang
Rong Tang
WWWei Wang
Wei Wang
BZBo Zhang
Bo Zhang
SSSi Shi
Si Shi
Objective. Pancreatic ductal adenocarcinoma (PDAC) is a lethal solid gastrointestinal malignancy with poor immune infiltration and a limited response to immunotherapy. The aim of our study was to explore the predictive value of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs), which are widely expressed in various tumor cells. Methods. Transcriptomic data with follow-up information were obtained from the GEO, TCGA and ArrayExpress. The Kaplan–Meier (KM) method and univariate Cox (UniCox) proportional hazard regression were used to show the survival outcomes of the groups. Immune infiltration was analyzed using the online databases TISCH, TISIDB, TIMER2.0, and TIDE as well as the R packages “estimate” and “GSVA.” Mutation and functional enrichment analyses were conducted using the R packages “maftools,” “clusterProfiler,” and online repository HOME for Researchers. Finally, the results were validated in 79 samples from our cancer center. Results. Survival analysis using public databases and the FUSCC cohort indicated PDGFRA to be associated with prolonged overall survival (OS) (both ). PDGFRA expression was highest in cancer-associated fibroblasts (CAFs) of PDAC, as validated in public databases and cell lines from our cancer center. The high expression of PDGFRA was associated with increased immune infiltration and potent T cell cytotoxicity in PDAC. Conclusion. In summary, high PDGFRA expression is associated with increased immune infiltration and prolonged OS. This finding might provide a new strategy for regulating immune cell infiltration in PDAC and improving the efficacy of immunotherapy.

16 December 2024
Verified
Other
Open access
ZRZeyin Rong
Zeyin Rong
JXJin Xu
Jin Xu
JYJianhui Yang
Jianhui Yang
WWWei Wang
Wei Wang
RTRong Tang
Rong Tang
SSSi Shi
Si Shi
Supplementary Materials and methods Supplementary Figures S1 to S17 Supplementary Tables S1 to S7

17 June 2026
Verified
Other
Open access
PDF file
ZRZeyin Rong
Zeyin Rong
JXJin Xu
Jin Xu
JYJianhui Yang
Jianhui Yang
WWWei Wang
Wei Wang
RTRong Tang
Rong Tang
SSSi Shi
Si Shi
Supplementary Materials and methods Supplementary Figures S1 to S17 Supplementary Tables S1 to S7

17 June 2026
Verified
Other
Open access
ZRZeyin Rong
Zeyin Rong
JXJin Xu
Jin Xu
JYJianhui Yang
Jianhui Yang
WWWei Wang
Wei Wang
RTRong Tang
Rong Tang
SSSi Shi
Si Shi
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal tumor with limited treatment options and poor patient survival. Circular RNAs (circRNA) play crucial regulatory roles in the occurrence and development of various cancers, including PDAC. In this study, using circRNA sequencing of diverse PDAC samples, we identified circRREB1 as an oncogenic circRNA that is significantly upregulated in PDAC and is correlated with an unfavorable patient prognosis. Functionally, loss of circRREB1 markedly inhibited glycolysis and stemness, whereas elevated circRREB1 elicited the opposite effects. Mechanistically, circRREB1 interacted with PGK1, disrupting the association between PTEN and PGK1 and increasing PGK1 phosphorylation to activate glycolytic flux. Moreover, circRREB1 promoted WNT7B transcription by directly interacting with YBX1 and facilitating its nuclear translocation, consequently activating the Wnt/β-catenin signaling pathway to maintain PDAC stemness. Overall, these results highlight circRREB1 as a key regulator of metabolic and stemness properties of PDAC.Significance:CircRREB1 stimulates PGK1 to induce glycolysis and activates the Wnt/β-catenin signaling pathway to maintain stemness in pancreatic cancer, indicating the potential of circRREB1 as a biomarker and therapeutic target.